Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CVS
CVS logo

CVS Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
92.770
Open
91.155
VWAP
91.87
Vol
12.02M
Mkt Cap
117.67B
Low
90.630
Amount
1.10B
EV/EBITDA(TTM)
9.48
Total Shares
1.28B
EV
167.03B
EV/OCF(TTM)
16.17
P/S(TTM)
0.28
CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.
Show More

Events Timeline

No data

No data

News

Yahoo Finance
9.5
05-10Yahoo Finance
CVS Health Q1 Earnings Exceed Expectations
  • Earnings Beat: CVS Health reported an adjusted EPS of $2.57 for Q1 2026, surpassing Morgan Stanley's estimate of $2.17, indicating effective medical cost management and boosting investor confidence.
  • Significant Revenue Growth: Total revenues reached $100.4 billion, a 6.2% year-over-year increase, reflecting the company's competitive position in the market and laying a foundation for future growth.
  • Improved Medical Benefit Ratio: The medical benefit ratio stood at 84.6%, significantly below Morgan Stanley's estimate of 86.0%, demonstrating CVS's superior performance in managing medical costs, enhancing its appeal in the managed care sector.
  • Guidance Raise: CVS raised its full-year adjusted EPS guidance to $7.30 to $7.50 and increased cash flow guidance to at least $9.5 billion, showcasing the company's confidence in future performance and a positive market outlook.
Newsfilter
9.5
05-07Newsfilter
CVS Health Reports Strong Q1 Earnings and Raises 2026 Guidance
  • Strong Earnings Performance: CVS Health reported Q1 earnings that exceeded market expectations, with specific figures not disclosed, indicating robust performance in the healthcare sector and boosting investor confidence.
  • Raised 2026 Guidance: The company has raised its financial guidance for 2026, reflecting an optimistic outlook for future growth, which may attract more investor interest and elevate stock prices.
  • Analyst Positive Outlook: Several analysts have expressed a positive outlook on CVS Health, raising their price targets, indicating market recognition of the company's sustained growth potential, which could further drive stock price increases.
  • Positive Market Reaction: Following the upbeat earnings and raised guidance, CVS Health's stock price reacted positively in the market, expected to attract more capital inflows and strengthen the company's market position in the healthcare industry.
CNBC
9.5
05-07CNBC
Market Dynamics and Company Performance Analysis
  • Calm Market Conditions: Stock futures are stable this morning with oil prices down approximately 5%, following another record close for the S&P 500, driven by hopes for an end to the Iran war, although the market is inching towards overbought territory according to momentum indicators.
  • Arm Holdings Earnings Report: Despite a strong earnings report from Arm Holdings showcasing robust data center CPU business, shares fell 8% this morning due to insufficient supply of new CPUs to raise revenue forecasts, even though they are more power-efficient than AMD and Intel's x86 processors.
  • Fortinet Share Surge: Fortinet's stock surged 15% after delivering outstanding quarterly results, prompting BTIG analysts to upgrade the stock from hold to buy, with Fortinet commanding 50% of the global firewall market, boosting the performance of other cybersecurity stocks as well.
  • Kraft Heinz Recovery Plan: Although Kraft Heinz has struggled for years, CEO Steve Cahillane is investing in brands like Kraft mac and cheese to restore the company's former glory, aiming to win back consumers and drive growth, reflecting confidence in future prospects.
moomoo
6.0
05-07moomoo
CVS HEALTH: BARCLAYS INCREASES TARGET PRICE FROM $93 TO $101
  • CVS Health Target Price Increase: Barclays has raised the target price for CVS Health from $93 to $101.
  • Market Implications: This adjustment reflects Barclays' positive outlook on CVS Health's performance and potential growth in the market.
Fool
9.5
05-07Fool
CVS Health Exceeds Expectations in Q1 Results
  • Strong Performance: CVS Health reported first-quarter revenue exceeding $100 billion, reflecting a 6% year-over-year increase, which bolstered investor confidence and led to an almost 8% rise in stock price.
  • Significant Net Income Growth: Under GAAP, CVS's net income surged by 66% to nearly $2.96 billion, with adjusted EPS at $2.57, surpassing analyst expectations and showcasing a notable improvement in profitability.
  • Market Expectations Surpassed: Analysts had estimated CVS's revenue at just over $95 billion, but the actual results exceeded these projections, highlighting the company's strong presence in the pharmacy market and its unique business structure.
  • Optimistic Outlook: CVS raised its adjusted EPS guidance to between $7.30 and $7.50, with projected annual revenue of at least $405 billion, indicating the company's potential for sustained growth in a competitive landscape.
NASDAQ.COM
4.5
05-06NASDAQ.COM
US Stocks Surge as Tech Stocks Lead Gains
  • Tech Stocks Rally: The Nasdaq 100 surged 2.08% to reach an all-time high on Wednesday, driven by stellar earnings from chipmakers and AI infrastructure firms, particularly Advanced Micro Devices, which rose over 17% as it raised its full-year sales forecast, reflecting strong investor optimism about ongoing AI investments.
  • Crude Oil Plunge: WTI crude oil prices fell more than 7% to a two-week low as market expectations for a US-Iran peace agreement increased, easing inflation fears and contributing to stock market gains, with the 10-year Treasury yield dropping to a one-week low of 4.33%.
  • Employment Data Impact: The April ADP employment report indicated that US companies added 109,000 jobs, below the expected 120,000, yet the market remains optimistic about the Fed's monetary policy, believing it will help maintain a low interest rate environment.
  • International Market Surge: Overseas stock markets closed sharply higher, with the Euro Stoxx 50 rising 2.68% and China's Shanghai Composite gaining 1.17%, indicating a positive global market response to the US economic recovery, further boosting investor confidence.
Wall Street analysts forecast CVS stock price to rise
17 Analyst Rating
Wall Street analysts forecast CVS stock price to rise
16 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
91.00
Averages
96.71
High
105.00
Current: 0.000
sliders
Low
91.00
Averages
96.71
High
105.00
TD Cowen
Charles Rhyee
Buy
maintain
$105 -> $110
AI Analysis
2026-05-11
New
Reason
TD Cowen
Charles Rhyee
Price Target
$105 -> $110
AI Analysis
2026-05-11
New
maintain
Buy
Reason
TD Cowen analyst Charles Rhyee raised the firm's price target on CVS Health to $110 from $105 and keeps a Buy rating on the shares. The firm said they remain positive on CVS shares, as they view its raised 2026 as a conservative target, particularly in HCB, where management raised its guide for above expectations.
Wells Fargo
Stephen Baxter
Overweight
maintain
$102 -> $103
2026-05-08
New
Reason
Wells Fargo
Stephen Baxter
Price Target
$102 -> $103
2026-05-08
New
maintain
Overweight
Reason
Wells Fargo analyst Stephen Baxter raised the firm's price target on CVS Health to $103 from $102 and keeps an Overweight rating on the shares. The firm is constructive on Q1 results and optionality for positive earnings revisions through 2026 given conservative approach to Health Care Benefits guidance. Wells is increasing estimates by net favorable PYD and stronger PCW performance.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CVS
Unlock Now

Valuation Metrics

The current forward P/E ratio for CVS Health Corp (CVS.N) is 11.27, compared to its 5-year average forward P/E of 10.33. For a more detailed relative valuation and DCF analysis to assess CVS Health Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
10.33
Current PE
11.27
Overvalued PE
11.73
Undervalued PE
8.93

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.26
Current EV/EBITDA
9.72
Overvalued EV/EBITDA
14.73
Undervalued EV/EBITDA
5.79

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.29
Current PS
0.26
Overvalued PS
0.38
Undervalued PS
0.20

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

option with low spread for today
Intellectia · 192 candidates
Price: $20.00 - $500.00Market Cap Category: large, midRelative Vol: >= 1Is Optionable: TrueOption Iv Rank: 20 - 60Is Index Component: GSPC, NDX, DJI, RUT
Ticker
Name
Market Cap$
top bottom
NEE logo
NEE
Nextera Energy Inc
194.60B
DIS logo
DIS
Walt Disney Co
188.69B
BA logo
BA
Boeing Co
182.12B
ANET logo
ANET
Arista Networks Inc
178.49B
TMO logo
TMO
Thermo Fisher Scientific Inc
176.32B
T logo
T
AT&T Inc
175.52B
I need AI to pick a stock and manage it
Intellectia · 2 candidates
Sector: Healthcare, Healthcare Services & Equipment, Pharmaceuticals & Medical ResearchIndustry: Food & Drug Retailing, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsVolume: >= -100Themes: Medical Instruments & Supplies, Pharmaceutical RetailersRsi Category: moderateMoving Average Relationship: PriceAboveMA5, PriceAboveMA20Monthly Average Dollar Volume: >= -100Macd: positive, bullish
Ticker
Name
Market Cap$
top bottom
CVS logo
CVS
CVS Health Corp
103.78B
EW logo
EW
Edwards Lifesciences Corp
47.44B
which stocks to buy short term
Intellectia · 40 candidates
Moving Average Relationship: PriceAboveMA20Week Price Change Pct: $4.00 - $12.00Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
ELV logo
ELV
Elevance Health Inc
74.87B
QCOM logo
QCOM
Qualcomm Inc
158.82B
VTR logo
VTR
Ventas Inc
39.76B
KDP logo
KDP
Keurig Dr Pepper Inc
39.76B
PKG logo
PKG
Packaging Corp of America
18.95B
BKR logo
BKR
Baker Hughes Co
68.37B
today's stock picks
Intellectia · 74 candidates
Volume: >= 1,000,000Price Change Pct: $1.00 - $10.00List Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Is Index Component: GSPC, NDX
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
329.83B
NUE logo
NUE
Nucor Corp
48.80B
MOH logo
MOH
Molina Healthcare Inc
9.17B
BEN logo
BEN
Franklin Resources Inc
14.12B
UDR logo
UDR
UDR Inc
11.42B
AVB logo
AVB
AvalonBay Communities Inc
23.98B
yes stocks
Intellectia · 27 candidates
Market Cap: >= 50.00BDividend Yield Ttm: 2.50 - 6Analyst Consensus: Strong Buy, Moderate BuyBeta: LowRiskRevenue 5yr Cagr: >= 7
Ticker
Name
Market Cap$
top bottom
XOM logo
XOM
Exxon Mobil Corp
618.95B
CVX logo
CVX
Chevron Corp
368.92B
KO logo
KO
Coca-Cola Co
329.83B
UNH logo
UNH
UnitedHealth Group Inc
322.34B
MRK logo
MRK
Merck & Co Inc
276.38B
PM logo
PM
Philip Morris International Inc
255.91B
stock of the day
Intellectia · 13 candidates
Market Cap: >= 5.00BPrice Change Pct: >= $3.00Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAR logo
CAR
Avis Budget Group Inc
6.73B
SSL logo
SSL
Sasol Ltd
7.96B
UNH logo
UNH
UnitedHealth Group Inc
255.38B
PSKY logo
PSKY
Paramount Skydance Corp
10.95B
HUM logo
HUM
Humana Inc
21.93B
AAOI logo
AAOI
Applied Optoelectronics Inc
8.35B
money market funds
Intellectia · 68 candidates
Market Cap: >= 1000.00MRegion: USBeta: LowRisk, NegativeBetaList Exchange: XNYS, XNAS, XASEYear Price Change Pct: $2.00 - $8.00Monthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
321.48B
PM logo
PM
Philip Morris International Inc
252.94B
T logo
T
AT&T Inc
201.96B
CB logo
CB
Chubb Ltd
126.84B
SO logo
SO
Southern Co
106.81B
DUK logo
DUK
Duke Energy Corp
100.69B
best stocks to short
Intellectia · 70 candidates
Market Cap: >= 1000.00MPe Ttm: >= 40List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceBelowMA200Annual Eps Yoy Growth: <= -10.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
TSLA logo
TSLA
Tesla Inc
1.38T
SHOP logo
SHOP
Shopify Inc
152.29B
PANW logo
PANW
Palo Alto Networks Inc
132.97B
COF logo
COF
Capital One Financial Corp
112.86B
CEG logo
CEG
Constellation Energy Corp
102.16B
CVS logo
CVS
CVS Health Corp
90.94B
which has the highest return?
Intellectia · 14 candidates
Market Cap: >= 5.00BRegion: USPrice: $10.00 - $150.00One Day Rise Prob: >= 60One Day Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 3,000,000
Ticker
Name
Market Cap$
top bottom
LNC logo
LNC
Lincoln National Corp
6.85B
CVS logo
CVS
CVS Health Corp
96.93B
RRR logo
RRR
Red Rock Resorts Inc
6.46B
PINS logo
PINS
Pinterest Inc
11.69B
MFC logo
MFC
Manulife Financial Corp
59.36B
QGEN logo
QGEN
Qiagen NV
10.06B
accion que comprar hoy para corto plazo
Intellectia · 399 candidates
Market Cap: >= 5.00BRsi Category: moderateList Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20One Week Predict Return: >= 0.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMFG logo
SMFG
Sumitomo Mitsui Financial Group Inc
134.12B
APG logo
APG
APi Group Corp
18.03B
SAN logo
SAN
Banco Santander SA
182.13B
CMI logo
CMI
Cummins Inc
78.93B
SMR logo
SMR
Nuscale Power Corp
5.98B
GDS logo
GDS
GDS Holdings Ltd
8.53B

Whales Holding CVS

M
Mubadala Investment Company PJSC
Holding
CVS
+51.45%
3M Return
M
Maple Rock Capital Partners Inc.
Holding
CVS
+28.02%
3M Return
M
Moore Capital Management, LP
Holding
CVS
+21.24%
3M Return
B
BW Gestao de Investimentos Ltda.
Holding
CVS
+17.20%
3M Return
B
Bridgewater Associates
Holding
CVS
+16.31%
3M Return
A
Argenta Asset Management SA
Holding
CVS
+16.11%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is CVS Health Corp (CVS) stock price today?

The current price of CVS is 92.22 USD — it has increased 1.84

What is CVS Health Corp (CVS)'s business?

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

What is the price predicton of CVS Stock?

Wall Street analysts forecast CVS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CVS is96.71 USD with a low forecast of 91.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is CVS Health Corp (CVS)'s revenue for the last quarter?

CVS Health Corp revenue for the last quarter amounts to 100.43B USD, increased 6.17

What is CVS Health Corp (CVS)'s earnings per share (EPS) for the last quarter?

CVS Health Corp. EPS for the last quarter amounts to 2.30 USD, increased 63.12

How many employees does CVS Health Corp (CVS). have?

CVS Health Corp (CVS) has 300000 emplpoyees as of May 12 2026.

What is CVS Health Corp (CVS) market cap?

Today CVS has the market capitalization of 117.67B USD.